Redwood Wealth Management Group’s AbbVie ABBV Stock Holding History

Redwood Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,427	Closed	-$963K	–	2
2026 Q1	$963K	Sell	4,427 -66	-1%	-$14.6K	0.42%	54
2025 Q4	$1.03M	Sell	4,493 -16	-0.4%	-$3.65K	0.43%	54
2025 Q3	$1.04M	Sell	4,509 -130	-3%	-$26.5K	0.44%	54
2025 Q2	$861K	Sell	4,639 -34	-0.7%	-$6.32K	0.39%	52
2025 Q1	$979K	Sell	4,673 -26	-0.6%	-$5.05K	0.5%	48
2024 Q4	$835K	Sell	4,699 -17	-0.4%	-$3.13K	0.41%	54
2024 Q3	$931K	Buy	4,716 +21	+0.4%	+$3.92K	0.46%	52
2024 Q2	$805K	Sell	4,695 -154	-3%	-$25.5K	0.61%	32
2024 Q1	$883K	Sell	4,849 -190	-4%	-$32.7K	0.94%	30
2023 Q4	$781K	Sell	5,039 -420	-8%	-$61.2K	0.87%	29
2023 Q3	$814K	Sell	5,459 -48	-0.9%	-$7.05K	0.95%	26
2023 Q2	$742K	Sell	5,507 -366	-6%	-$53.7K	0.82%	31
2023 Q1	$936K	Buy	5,873 +177	+3%	+$27.1K	1.06%	23
2022 Q4	$921K	Buy	+5,696	New	+$873K	1.15%	19

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Redwood Wealth Management Group's ABBV Position: Q2 2026 in Review

Redwood Wealth Management Group sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 4,427 shares — an estimated $963K sold.

Redwood Wealth Management Group first reported a position in ABBV in Q4 2022 and held it in 14 quarters. The position peaked at $1.04M in Q3 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Redwood Wealth Management Group reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Redwood Wealth Management Group sold 4,427 AbbVie shares in Q2 2026, an estimated $963K.
Redwood Wealth Management Group first reported a position in AbbVie in Q4 2022 and held it in 14 quarters.
Redwood Wealth Management Group's AbbVie position peaked at $1.04M in Q3 2025.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Redwood Wealth Management Group's 13F filing for Q2 2026.